Immutep IMMP
NASDAQ IMMP
$0.39 0.00 (-1.28%)
At close: Aug 21, 2026 · 4:00 PM EDT

Immutep (IMMP) Accumulated Expenses (2016 - 2025)

Immutep's (IMMP) quarterly Accumulated Expenses came in at $6.7 million in Q4 2025, up 298.34% YoY from $1.7 million in Q4 2024, and up 125.82% on a QoQ basis from $3.0 million in Q2 2025.

Immutep (IMMP) Accumulated Expenses (2016 - 2025) Analysis & Trends

Immutep (IMMP) has 10 years of Accumulated Expenses data on file, last reported at $6.7 million in Q4 2025.

  • Quarterly Accumulated Expenses rose 298.34% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.7 million (up 298.34% YoY) and the FY2025 annual result came in at $3.0 million, up 554.92% from the prior year.
  • Accumulated Expenses grew to $6.7 million in Q4 2025, from $3.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $6.7 million in Q4 2025 to a low of $42.98 in Q4 2021.
  • A 5-year average of $1.6 million and a median of $415460.5 in 2023 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2021 — Accumulated Expenses sank 98.61% — and 2025, when it surged 554.92%.
  • Tracing IMMP's Accumulated Expenses over 5 years: stood at $42.98 in 2021, then surged by 594872.97% to $255728.6 in 2022, then soared by 46.96% to $375819.7 in 2023, then jumped by 349.6% to $1.7 million in 2024, then jumped by 298.34% to $6.7 million in 2025.
  • The last three Accumulated Expenses figures came in at $6.7 million (Q4 2025), $3.0 million (Q2 2025), and $1.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Immutep 56.46 Mn -8.63 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 6.73 Mn
Jun 30, 2025 2.98 Mn
Dec 31, 2024 1.69 Mn
Jun 30, 2024 455,101.22
Jun 30, 2023 375,819.75
Jun 30, 2022 255,728.56
Dec 31, 2021 42.98
Jun 30, 2021 269,623.26
Dec 31, 2020 3,087.47
Jun 30, 2020 196,931.61
Dec 31, 2019 9,883.01
Jun 30, 2019 167,111.67
Jun 30, 2018 143,469.09
Jun 30, 2017 32,472.57
Mar 31, 2017 73.48
Jun 30, 2016 152.33